Intellia Therapeutics Announces Second Quarter 2020 Financial Results
Submitted first regulatory application to the U.K.’s MHRA to initiate a Phase 1 study of NTLA-2001 for the treatment of […]
Alico, Inc. Announces Two New Appointments to the Board of Directors
FORT MYERS, Fla., Aug. 06, 2020 (GLOBE NEWSWIRE) — Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announces the […]
Adaptimmune Reports Q2 Financial Results and Business Update
– Reported responses in multiple solid tumor types during ASCO with updates at upcoming congresses in Q4 –– Continued progress […]
Albireo Reports Q2 2020 Financial Results and Provides Business Update
— Completed last patient visits in Phase 3 PFIC and Phase 2 NASH Trials —— Enrolled first biliary atresia patients in […]
US Tier-1 Mobile Operator Awards Gilat a Multi-Million Dollar Service Contract for Cellular Backhaul
PETAH TIKVA, Israel, Aug. 06, 2020 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in […]
Sol-Gel Technologies Reports Second Quarter 2020 Financial Results and Corporate Update
New Drug Application for Epsolay® Submitted; Twyneo® New Drug Application on track for 2H 2020Top-line generic product revenue of $1.1 […]
Myriad to Announce Fiscal Fourth-Quarter and Full Fiscal Year 2020 Financial Results on August 13, 2020
SALT LAKE CITY, Aug. 06, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and […]
Corbus Pharmaceuticals Reports Second Quarter Financial Results and Corporate Updates
RESOLVE-1 Phase 3 study of lenabasum for treatment of systemic sclerosis on schedule for topline data this summerPhase 2b study […]
Zynerba Pharmaceuticals to Present at the Virtual 40th Annual Canaccord Genuity Growth Conference
DEVON, Pa., Aug. 06, 2020 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies […]
Immatics Extends Cell Therapy Manufacturing Collaboration with UTHealth
Houston, Texas, Aug. 06, 2020 (GLOBE NEWSWIRE) — Extension of collaboration between UTHealth and Immatics until end of 2024 providing […]
